Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology (Q44746659)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 September 2013
edit
Language Label Description Also known as
English
Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology
scientific article published on 5 September 2013

    Statements

    Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology (English)
    Stanley A Roberts
    Paul A Andrews
    Diann Blanset
    Kelly M Flagella
    Boris Gorovits
    Carmel M Lynch
    Pauline L Martin
    Kimberly Kramer-Stickland
    Stephane Thibault
    Garvin Warner
    5 September 2013
    382-391

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit